Jan Chemnitz

826 total citations
19 papers, 674 citations indexed

About

Jan Chemnitz is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Jan Chemnitz has authored 19 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Virology. Recurrent topics in Jan Chemnitz's work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers) and HIV Research and Treatment (5 papers). Jan Chemnitz is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers) and HIV Research and Treatment (5 papers). Jan Chemnitz collaborates with scholars based in Germany, Switzerland and United States. Jan Chemnitz's co-authors include Joachim Hauber, Jochen Heukeshoven, Ralph H. Kehlenbach, Ilona Hauber, Gabor Rohaly, Irena Dornreiter, Silke Dehde, Wolfgang Deppert, Frank Buchholz and Adam Grundhoff and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jan Chemnitz

19 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Chemnitz Germany 13 537 150 120 94 80 19 674
Panpan Hou China 13 488 0.9× 85 0.6× 101 0.8× 139 1.5× 104 1.3× 20 666
Gwendolyn Μ. Jang United States 13 348 0.6× 111 0.7× 35 0.3× 82 0.9× 93 1.2× 23 575
Mourad Bendjennat United States 11 405 0.8× 241 1.6× 35 0.3× 54 0.6× 73 0.9× 18 631
Mariana Pavon-Eternod United States 7 947 1.8× 115 0.8× 59 0.5× 160 1.7× 140 1.8× 9 1.1k
О. С. Таранов Russia 14 274 0.5× 136 0.9× 74 0.6× 133 1.4× 178 2.2× 76 552
Anitha Rao United States 6 444 0.8× 96 0.6× 247 2.1× 67 0.7× 217 2.7× 13 570
Laura Marcos-Villar Spain 19 476 0.9× 219 1.5× 103 0.9× 246 2.6× 40 0.5× 32 799
Jaydip Das Gupta United States 15 348 0.6× 87 0.6× 158 1.3× 332 3.5× 72 0.9× 23 774
Karine Mollier France 12 240 0.4× 90 0.6× 138 1.1× 181 1.9× 106 1.3× 14 519
Ann Brasey Canada 6 278 0.5× 69 0.5× 76 0.6× 118 1.3× 68 0.8× 9 433

Countries citing papers authored by Jan Chemnitz

Since Specialization
Citations

This map shows the geographic impact of Jan Chemnitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Chemnitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Chemnitz more than expected).

Fields of papers citing papers by Jan Chemnitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Chemnitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Chemnitz. The network helps show where Jan Chemnitz may publish in the future.

Co-authorship network of co-authors of Jan Chemnitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Chemnitz. A scholar is included among the top collaborators of Jan Chemnitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Chemnitz. Jan Chemnitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chemnitz, Jan, Lena Stich, Udo Schumacher, et al.. (2019). The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice. Scientific Reports. 9(1). 4853–4853. 13 indexed citations
2.
Hauber, Ilona, et al.. (2018). Improving Lentiviral Transduction of CD34 + Hematopoietic Stem and Progenitor Cells. Human Gene Therapy Methods. 29(2). 104–113. 29 indexed citations
3.
Martínez-Rocha, Ana Lilia, Jan Chemnitz, Peter Willingmann, et al.. (2016). Posttranslational hypusination of the eukaryotic translation initiation factor-5A regulates Fusarium graminearum virulence. Scientific Reports. 6(1). 24698–24698. 15 indexed citations
4.
Hauber, Ilona, Jan Chemnitz, Carola Schäfer, et al.. (2016). Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nature Biotechnology. 34(4). 401–409. 95 indexed citations
5.
Geißler, René, Ilona Hauber, Jan Chemnitz, et al.. (2015). Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study. Virology. 486. 248–254. 5 indexed citations
6.
Karimova, Madina, Werner Dammermann, Jan Chemnitz, et al.. (2015). CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X. Scientific Reports. 5(1). 13734–13734. 103 indexed citations
7.
Karimova, Madina, Werner Dammermann, Jan Chemnitz, et al.. (2015). CRISPR/Cas9 “double”-nickase mediated inactivation of hepatitis B virus replication. Zeitschrift für Gastroenterologie. 53(12). 1 indexed citations
8.
Chemnitz, Jan, Ilona Hauber, Josephine Abi‐Ghanem, et al.. (2014). Universal Tre (uTre) recombinase specifically targets the majority of HIV‐1 isolates. Journal of the International AIDS Society. 17(4S3). 19706–19706. 9 indexed citations
9.
Hauber, Joachim, Ilona Hauber, Jan Chemnitz, et al.. (2014). Next-generation LTR-specific Tre-recombinase targets a majority of HIV-1 isolates. BMC Infectious Diseases. 14(S2). 6 indexed citations
10.
Hauber, Ilona, Jan Chemnitz, Janet Chusainow, et al.. (2013). Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice. PLoS Pathogens. 9(9). e1003587–e1003587. 47 indexed citations
11.
Kehlenbach, Ralph H., et al.. (2012). Post-transcriptional regulation of CD83 expression by AUF1 proteins. Nucleic Acids Research. 41(1). 206–219. 8 indexed citations
12.
Prechtel, Alexander, et al.. (2011). Functional Characterization of the HuR:CD83 mRNA Interaction. PLoS ONE. 6(8). e23290–e23290. 16 indexed citations
13.
Chemnitz, Jan, Nadine M. Turza, Ilona Hauber, Alexander Steinkasserer, & Joachim Hauber. (2009). The karyopherin CRM1 is required for dendritic cell maturation. Immunobiology. 215(5). 370–379. 10 indexed citations
14.
Chemnitz, Jan, et al.. (2009). Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression. European Journal of Immunology. 39(1). 267–279. 16 indexed citations
15.
Schütz, Sylvia, Jan Chemnitz, Christiane Spillner, et al.. (2006). Stimulated Expression of mRNAs in Activated T Cells Depends on a Functional CRM1 Nuclear Export Pathway. Journal of Molecular Biology. 358(4). 997–1009. 29 indexed citations
16.
Heukeshoven, Jochen, Ilona Hauber, Carol Stocking, et al.. (2006). Analysis of Nucleocytoplasmic Trafficking of the HuR Ligand APRIL and Its Influence on CD83 Expression. Journal of Biological Chemistry. 282(7). 4504–4515. 54 indexed citations
17.
Prechtel, Alexander, Jan Chemnitz, Jörg Stülke, et al.. (2006). Expression of CD83 Is Regulated by HuR via a Novel cis-Active Coding Region RNA Element. Journal of Biological Chemistry. 281(16). 10912–10925. 67 indexed citations
18.
Rohaly, Gabor, Jan Chemnitz, Silke Dehde, et al.. (2005). A Novel Human p53 Isoform Is an Essential Element of the ATR-Intra-S Phase Checkpoint. Cell. 122(1). 21–32. 118 indexed citations
19.
Dehde, Silke, Gabor Rohaly, Heinz‐Peter Nasheuer, et al.. (2001). Two Immunologically Distinct Human DNA Polymerase α-Primase Subpopulations Are Involved in Cellular DNA Replication. Molecular and Cellular Biology. 21(7). 2581–2593. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026